본문 바로가기
KERD
논문KCI 등재

Reply to correspondence on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

참고문헌 (7)

  1. Fujii H, "Correspondence on Letter regarding"Prognosis of biopsy-confirmed MASLD : A sub-analysis of the CLIONE study"", Clin Mol Hepatol, 30, pp.281~283 (2024)
  2. Oh JH, "Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease(MASLD) : Insights into regional and ethnic differences", Clin Mol Hepatol, 30, pp.168~170 (2024)
  3. Iwaki M, "Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease : A sub-analysis of the CLIONE study", Clin Mol Hepatol, 30, pp.225~234 (2024)
  4. Sanyal AJ, "Prospective study of outcomes in adults with nonalcoholic fatty liver disease", N Engl J Med, 385, pp.1559~1569 (2021)
  5. Yoon EL, "Correspondence on Letter regarding"Risk factors in nonalcoholic fatty liver disease"", Clin Mol Hepatol, 29, pp.1050~1051 (2023)
  6. Ko E, "Risk factors in nonalcoholic fatty liver disease", Clin Mol Hepatol, 29(Suppl), pp.S79~S85 (2023)
  7. Lee CM, "Prevalence, distribution, and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings", Hepatology, 79, pp.1393~1400 (2024)

관련 논문AI추천

Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”Jie Li, Junping Shi, Wenjing Ni, Xiaoyan Ma, Yee Hui Yeo, Yixuan Zhu대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Correspondence on Letter regarding “Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study”Hideki Fujii, Michihiro Iwaki, Yoshihiro Kamada대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제2호Correspondence to editorial on “Risk stratification by noninvasive tests in patients with metabolic dysfunc tion-associated steatotic liver disease”Hye Won Lee, Seung Up Kim대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”김문영, 백순구, Seul Ki Han대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제3호Reply to correspondence on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”Jian-Gao Fan, Jing Zeng대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence to letter to the editor 1 on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”Sang Min Park, Seogsong Jeong, Won Kim대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호

이 간행물의 다른 논문 (78건)